Skip to content

Advertisement

  • Poster presentation
  • Open Access

Matching trial design decisions to the needs of those you hope will use the results: the PRECIS-2 tool

  • 1,
  • 3,
  • 4,
  • 2 and
  • 1
Trials201516 (Suppl 2) :P223

https://doi.org/10.1186/1745-6215-16-S2-P223

  • Published:

Keywords

  • Team Member
  • Healthcare Professional
  • Design Decision
  • Potential User
  • Routine Care

Randomised trials are hard work. Like much that is hard, this toil is only worth it because of the prospect of a substantial reward. Sadly, the reward to potential users such as patients, healthcare professionals and policy makers is often smaller than it should be because trial design decisions reduced the relevance of the trial to them.

PRECIS-2 is a tool designed to help trialists match their design decisions to the information needs of those they hope will use the trial results. It is an update of the 2009 PRECIS tool, which though highly cited had some well-known weaknesses. PRECIS-2 was developed in collaboration with over 80 international trialists, methodologists and others to produce a tool that addressed those weaknesses but also supports improved design insight for trialists.

PRECIS-2 retains the wheel format of the original tool. It has nine design domains including Eligibility, Recruitment, Setting and Primary outcome. A new domain - Organisation - is explicitly aimed at making trialists consider the resource requirements their intervention will place on health care systems if it were to be rolled out into routine care, the intention being to think about implementation at the design stage. The highly visual presentation makes inconsistent decision-making immediately obvious; it also highlights differences of opinion between trial team members.

We will present the tool, explain how to use it and show examples of how it has been used already. This work is part of the Trial Forge initiative to improve trial efficiency.

Authors’ Affiliations

(1)
University of Aberdeen, Aberdeen, UK
(2)
University of Dundee, Dundee, UK
(3)
Western University, London, Canada
(4)
University of Toronto, Toronto, Canada

Copyright

© Loudon et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement